SONM Earnings DNA X, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–18 of 18
| Q1 2026 | 2026-03-31 | 5.01 | 2026-05-20 | 10-Q |
| FY 2025 | 2025-12-31 | -28.58 | 2026-04-15 | 10-K |
| Q3 2025 | 2025-09-30 | -19.14 | 2025-10-31 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.91 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | 1.41 | 2026-05-20 | 10-Q |
| FY 2025 | 2024-12-31 | -128.37 | 2026-04-15 | 10-K |
| Q3 2025 | 2024-09-30 | -46.50 | 2025-10-31 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.09 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.65 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -0.02 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | 0.29 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.17 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.01 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -0.49 | 2024-03-27 | 10-K |
| Q3 2023 | 2022-09-30 | -0.52 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.60 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.38 | 2023-05-08 | 10-Q |
| Q1 2022 | 2021-03-31 | -1.40 | 2022-05-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.